Serum chloride was a strong and independent predictor of mortality at 6 months after a pulmonary arterial hypertension diagnosis.
The "egg-and-banana" sign is a valid computed tomography marker of pulmonary hypertension.
A protocolized study including initiation of VA-ECMO may reduce mortality in patients with massive PE.
Ischemic heart disease and kidney dysfunction were identified as 2 comorbidities that may affect outcomes in idiopathic pulmonary arterial hypertension.
Stem cell therapy targeting right ventricular failure may help improve pulmonary circulation in pulmonary arterial hypertension.
The sNDA is accompanied by results from the MERIT-1 trial, a Phase 2 randomized, placebo-controlled, double-blind study which assessed the efficacy, safety and tolerability of macitentan 10mg in 80 patients with inoperable CTEPH.
Walking a distance of >400 meters in the 6-minute walk test was associated with a reduced risk for pulmonary arterial hypertension-related death or hospitalization.
In patients with pulmonary arterial hypertension or distal chronic thromboembolic pulmonary hypertension, targeted pharmacologic treatment was associated with an increase in achieved therapeutic goals.
A 64-year-old man with chronic obstructive pulmonary disease, diabetes, chronic kidney disease, and morbid obesity seeks preoperative approval for femoral popliteal bypass surgery.
Pulmonary hypertension in heart failure with preserved ejection fraction is associated with mortalityApril 18, 2018
Pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF) is common in patients undergoing right heart catheterization. Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are predictors of mortality and cardiac hospitalizations in PH-HFpEF.
Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.
Prescribers tend to favor a frequency of 3 times per day for oral treprostinil dosing in patients with pulmonary arterial hypertension.
Patients with pulmonary hypertension have a high risk for adverse events during and following cardiac catheterization, but high case volume may help ameliorate this risk.
A 32-year-old woman presents to the emergency department with complaints of dyspnea on exertion and near syncopal episodes.
Nearly two-thirds of phosphodiesterase-5 inhibitor prescriptions are inconsistent with pulmonary hypertension guidelines.
Patients with pulmonary arterial hypertension may be better identified with the use of a claims-based algorithm that includes ICD-9-CM codes, electronic medical records, and more.
Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are associated with mortality in patients with pulmonary hypertension and heart failure with preserved ejection fraction.
Hemodynamic markers of pulmonary hypertension in heart failure with preserved ejection fraction are associated with mortalityMarch 20, 2018
Transpulmonary gradient, pulmonary vascular resistance, and diastolic pulmonary gradient are predictors of mortality and cardiac hospitalizations in pulmonary hypertension associated with heart failure with preserved ejection fraction.
Right atrium enlargement may predict the risk for supraventricular arrhythmias in patients with pulmonary arterial hypertension.
Women with pulmonary arterial hypertension may have better long-term prognoses compared with men, potentially because of improvements in right ventricular function.
A 3-month risk for a thromboembolic event was assessed using a pulmonary embolism rule-out criteria strategy and compared with a conventional strategy in patients with a low clinical probability of pulmonary embolism.
Acute pulmonary embolism may be managed in an outpatient setting when the patient has a low risk for mortality.
Hypoxemia is associated with reduced survival in patients with idiopathic or heritable pulmonary arterial hypertension.
Peak circulatory may provide reliable prognostic information in patients with idiopathic pulmonary arterial hypertension.
The 6MWT is a clinically relevant and appropriate target for patients with pulmonary arterial hypertension.
Several drugs may demonstrate different safety profiles and side effects that warrant a change in treatment for individuals with pulmonary hypertension.
To minimize the "learning effect" and improve accuracy, patients with suspected pulmonary hypertension should undergo two 6-minute walk tests.
Researchers discovered an association between global pulmonary vascular remodeling and pulmonary hypertension in patients with heart failure.
In a postmarketing surveillance study, ambrisentan demonstrated tolerability and potential effectiveness for pulmonary arterial hypertension treatment.
A pilot study will assess the effectiveness of milrinone in a small group of infants born with congenital diaphragmatic hernia.
The Cardiology Advisor Articles
- Oral Anticoagulant Effective in Recurrent VTE Prevention in Cancer Patients
- Updated Blood Pressure Guidelines Identify Children With Previously Underestimated Risk
- Egg-and-Banana Sign Has High Specificity for Pulmonary Hypertension Diagnosis
- Hyoscyamine Helps in Afib With Slow Ventricular Response
- AHA: Annual OB/GYN Appointment Can Benefit Women's Heart Health
- Tenecteplase Appears Superior to Alteplase After Ischemic Stroke
- Oxygen Therapy in Acute MI Not Associated With Clinical Benefit
- Hyoscyamine Helps in Afib With Slow Ventricular Response
- Deep Venous Thrombosis Ultrasound Protocol Recommendations
- Transforming Congenital Heart Disease Outcomes With 3D Printing
- International Liaison Committee on Resuscitation Identifies CPR Knowledge Gaps
- Coronary Heart Disease Mortality Often Attributed to Sudden Arrhythmic Death
- Doctors May Avoid Performing PCI Due to Public Reporting
- Best Practices Developed for Use of EHR to Enhance Patient Care
- FDA Approves Epoetin Alfa Biosimilar Retacrit